Carpenter, Thomas O.
Shaw, Nick J.
Portale, Anthony A.
Ward, Leanne M.
Abrams, Steven A.
Pettifor, John M.
Article History
First Online: 21 December 2017
Competing interests
: T.O.C. is a consultant for and is participating in clinical trials of burosumab with Ultragenyx Pharmaceutical and has served as a consultant for Alexion. A.A.P. has received honoraria from and is participating in a clinical trial of burosumab with Ultragenyx Pharmaceutical. L.M.W. has received honoraria from and is participating in a clinical trial of burosumab with Ultragenyx Pharmaceutical and has been a consultant to Alexion. J.M.P. is a consultant for Biomedical Systems Corporation. N.J.S. and S.A.A. declare no competing interests.